Venus Remedies Share Price
Small Cap | Pharmaceuticals and health care | NSE: VENUSREM | BSE: 526953
₹351.75 
3.15 (0.90 %)
Last Updated: 06 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 359.95
High (₹) 371.85
Low (₹) 338.40
Prev. Close (₹) 348.60
Volume 54,824
VWAP (₹) 341.73
ROCE (%) 8.17
Industry P/E 47.39
TTM P/E 13.49
P/B Ratio 0.96
Market Cap (₹) Cr.470.45
Dividend Yield (%)--
EPS (₹) 21.31
ROE5.84%
Sales Growth (%) 8.27
Profit Growth (%)7.25
Day Range
371.85371.85
52 Week Range
272.20427.30
Historical Returns
Returns (6M)
-10.79 %
Returns (1Y)
-9.06 %
Returns (3Y)
6.46 %
Returns (5Y)
1406.42 %
Returns (6M)
-10.79 %
Returns (1Y)
-9.06 %
Returns (3Y)
6.46 %
Returns (5Y)
1406.42 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (7.19%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Company with 7.19% positive TTM EPS growth
- Growth in Net Profit Margin (QoQ)
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- High CCI indicates strong upward momentum.
- Positive ROC (9) indicates upward momentum.
- Strong trend indicated by ADX above 25.
- Price above the pivot point indicates bullish sentiment.
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
BEARISHRSI 74.77
MFI 67.80
ATR 17.00
Commodity Channel Index 391.75
ROC125 -10.60
ROC21 14.94
Williams %R N/A
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 355.14 | 361.67 | 374.74 | 342.07 | 335.54 | 322.47 | 315.94 |
| Week Ago | 283.94 | 290.87 | 296.74 | 278.07 | 271.14 | 265.27 | 258.34 |
| Month Ago | 324.05 | 331.50 | 337.50 | 318.05 | 310.60 | 304.60 | 297.15 |
EMA & SMA
351.75
Current Price
Bullish Moving Averages
20
Bearish Moving Averages
0
5 Day 303.87
9 Day 294.72
10 Day 295.89
12 Day 297.41
14 Day 296.49
20 Day 297.43
26 Day 302.04
50 Day 309.19
100 Day 319.62
200 Day 334.54
Deals & Announcements
Bulk and Block Deals
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 31 May, 2022 | PAWAN CHAUDHARY | Acquisition | ₹217.3058387030705969467332567 | 1,26,946 | BSE |
| 20 Sept, 2021 | PAWAN CHAUDHARY Revised | Acquisition | ₹10.00 | 6,00,000 | BSE |
| 20 Sept, 2021 | MANU CHAUDHARY Revised | Acquisition | ₹10.00 | 4,25,000 | BSE |
| 04 Jun, 2021 | Pawan Chaudhary | Acquisition | ₹ | 6,00,000 | BSE |
| 04 Jun, 2021 | Manu Chaudhary | Acquisition | ₹ | 4,25,000 | BSE |
| 25 Feb, 2021 | MANU CHAUDHARY | Acquisition | ₹10.00 | 4,25,000 | BSE |
| 25 Feb, 2021 | PAWAN CHAUDHARY | Acquisition | ₹10.00 | 6,00,000 | BSE |
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 05 Feb, 2025 | BSE India | Integrated filing of Unaudited Financial results for the period ended on 31st December 2024. |
| 04 Feb, 2025 | NSE India | Venus Remedies Limited has informed the Exchange regarding ''''Intimation under Regulation 30 |
| 04 Feb, 2025 | BSE India | Intimation under Regulation 30 |
| 04 Feb, 2025 | BSE India | Unaudited financial results as on 31.12.2024 |
| 04 Feb, 2025 | NSE India | Venus Remedies Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024. |
| 04 Feb, 2025 | NSE India | Venus Remedies Limited has informed the Exchange regarding Board meeting held on February 04, 2025. |
| 24 Jan, 2025 | NSE India | VENUS REMEDIES LIMITED has informed the Exchange about Board Meeting to be held on 04-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 . |
| 24 Jan, 2025 | BSE India | VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 ,inter alia, to consider and approve Board meeting scheduled to be held on 04th February 2025 |
| 20 Jan, 2025 | NSE India | Venus Remedies Limited has informed the Exchange regarding ''Venus RemediesLimited successfullrenews EU GMP Certification''. |
| 20 Jan, 2025 | BSE India | Venus Remedies Limited successfully renews EU GMP |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 25 Jan, 2025 | 04 Feb, 2025 |
| Quarterly Results | -- | 21 Oct, 2024 | 29 Oct, 2024 |
| Quarterly Results & A.G.M. | -- | 02 Aug, 2024 | 13 Aug, 2024 |
| Others | 1. To consider the appointment of independent director. 2. To finalize the date of 35th Annual General Meeting of the company. | 20 Jul, 2024 | 20 Jul, 2024 |
| Audited Results | -- | 22 May, 2024 | 30 May, 2024 |
| Quarterly Results | -- | 05 Feb, 2024 | 14 Feb, 2024 |
| Quarterly Results | -- | 31 Oct, 2023 | 09 Nov, 2023 |
| Quarterly Results | -- | 07 Aug, 2023 | 14 Aug, 2023 |
| Others | -- | 06 Jul, 2023 | 14 Jul, 2023 |
| Audited Results | -- | 18 May, 2023 | 29 May, 2023 |
Share Holding Pattern
| Owner Name | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 | Sept, 2023 |
|---|
About Venus Remedies
Venus Remedies is a Public Limited Listed company incorporated on 15/09/1989 and has its registered office in the State of Chandigarh, India. Company’s Corporate Identification Number(CIN) is L24232CH1989PLC009705 and registration number is 009705. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 575.21 Cr. and Equity Capital is Rs. 13.37 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1989
Managing Director
Mr. Pawan Chaudhary
NSE Symbol
VENUSREM
Venus Remedies Management
| Name | Designation |
|---|---|
| Mr. Pawan Chaudhary | Chairman & Managing Director |
| Dr.(Mrs.) Manu Chaudhary | Joint Managing Director |
| Mr. Peeyush Jain | Deputy Managing Director |
| Mr. Ashutosh Jain | Executive Director |
| Mr. Akshansh Chaudhary | Executive Director |
| Dr.(Mrs.) Savita Gupta | Independent Director |
| Mr. N P S Monga | Independent Director |
| Mr. Navdeep Sud | Independent Director |
| Dr. Gilbert Wenzel | Independent Director |
| Dr. S K Chadha | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,742.00  ₹1,752.75(-0.61%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹6,119.70 ₹6,123.50(-0.06%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,471.50  ₹1,436.80(2.42%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,480.10 ₹2,483.00(-0.12%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,236.65 ₹1,227.55(0.74%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Venus Remedies
What is the share price of Venus Remedies?
The share price of Venus Remedies on 06 Feb, 2025 is ₹ 351.75.
What is 52W high and 52W low share price of Venus Remedies?
The highest and lowest 52W share prices of Venus Remedies are ₹ 429.600 and ₹ 280.000
What is the market cap of Venus Remedies?
The market capitalization of Venus Remedies as of 06 Feb, 2025 is ₹ 470.45 Crores
What is the P/E ratio of Venus Remedies?
The current P/E ratio of Venus Remedies as of 06 Feb, 2025 is 47.39
What is the PB ratio of Venus Remedies?
The PB ratio of Venus Remedies as of 06 Feb, 2025 is 0.96
Top Gainers
948IHFL26I
IBHFL NCD186
₹845
₹705 (0.2%)
GREAVESCOT
Greaves
₹281.85
₹234.9 (0.2%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.2%)
CAPRO
Caprola.Chem
₹62.4
₹52 (0.2%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.1%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.1%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0%)